Table 2.
Perioperative results.
| Variable | Total (n:76) | Open (n:50) | Robot-assisted (n:26) | p-value |
|---|---|---|---|---|
| pTNM (%) | 0.451 | |||
| pT2 | 25 (32.9) | 19 (38) | 6 (23.1) | |
| pT3a | 22 (28.9) | 13 (26) | 9 (34.6) | |
| pT3b | 24 (31.6) | 14 (28) | 10 (38.5) | |
| pT3b N1 | 5 (6.6) | 4 (8) | 1 (3.8) | |
| Gleason sum post-SRP (%) | 0.466 | |||
| 7 | 24 (31.6) | 18 (36) | 6 (23.1) | |
| 8 | 28 (36.8) | 18 (36) | 10 (38.5) | |
| 9 | 24 (31.6) | 14 (28) | 10 (38.5) | |
| Positive SM (%) | 22 (28.9) | 15 (30) | 7 (26.9) | 0.779 |
| Rectal injury (%) | 1 (1.3) | 0 | 1 (3.8) | 0.163 |
| Clavien-Dindo III-V (%) | 7 (9.2) | 4 (8) | 3 (11.5) | 0.613 |
| EBL median (IQR), ml | 150 (50-350) | 200 (50-400) | 150 (50-250) | 0.122 |
| Transfusion rate (%) | 2 (2.6) | 2 (4) | 0 | 0.301 |
| HS median (IQR), days | 3 (2-4) | 3 (2-4) | 2 (2-3) | 0.127 |
| Catheterization, days, median (IQR) | 15 (13-21) | 20 (15-21) | 13 (11-14) | 0.01 |
SM: surgical margin; pTNM: pathological tumor-node-metastasis; EBL: estimated blood loss; HS: hospital stay. Bold value indicates p-value less than 0.05 is statistically significant.